Skip to main content
Livermore
Livermore
ZHEN

Larimar Therapeutics, Inc.

LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374690

In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Larimar Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+9 vs. Q2 2021
Shares held
14.5M
−24.6K (−0.2%) vs. Q2 2021
Total value
$167.5M
+$24.7M (+17.3%) vs. Q2 2021
New holders
13
16 more added
Sold out
4
9 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 54 institutions
Q1 2021: 57 institutionsQ2 2021: 45 institutionsQ3 2021: 54 institutionsQ4 2021: 49 institutionsQ1 2022: 45 institutionsQ2 2022: 40 institutionsQ3 2022: 59 institutionsQ4 2022: 48 institutionsQ1 2023: 69 institutionsQ2 2023: 65 institutionsQ3 2023: 65 institutionsQ4 2023: 69 institutionsQ1 2024: 104 institutionsQ2 2024: 107 institutionsQ3 2024: 123 institutionsQ4 2024: 116 institutionsQ1 2025: 103 institutionsQ2 2025: 116 institutionsQ3 2025: 136 institutionsQ4 2025: 136 institutionsQ1 2026: 162 institutionsQ2 2026: 163 institutions
Value heldQ3 2021: $167.5M
Q1 2021: $206.1MQ2 2021: $142.8MQ3 2021: $167.5MQ4 2021: $157.2MQ1 2022: $61.8MQ2 2022: $28.2MQ3 2022: $123.9MQ4 2022: $160.1MQ1 2023: $174.2MQ2 2023: $120.2MQ3 2023: $153.0MQ4 2023: $179.6MQ1 2024: $482.8MQ2 2024: $473.5MQ3 2024: $421.3MQ4 2024: $245.5MQ1 2025: $131.9MQ2 2025: $180.1MQ3 2025: $274.8MQ4 2025: $277.0MQ1 2026: $394.8MQ2 2026: $291.4M
Institutions holding LRMR and their total value by quarter
QuarterHoldersValue
Q2 2026163$291.4M
Q1 2026162$394.8M
Q4 2025136$277.0M
Q3 2025136$274.8M
Q2 2025116$180.1M
Q1 2025103$131.9M
Q4 2024116$245.5M
Q3 2024123$421.3M
Q2 2024107$473.5M
Q1 2024104$482.8M
Q4 202369$179.6M
Q3 202365$153.0M
Q2 202365$120.2M
Q1 202369$174.2M
Q4 202248$160.1M
Q3 202259$123.9M
Q2 202240$28.2M
Q1 202245$61.8M
Q4 202149$157.2M
Q3 202154$167.5M
Q2 202145$142.8M
Q1 202157$206.1M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding LRMR in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Deerfield Management Company, L.P. (Series C)5,830,249$67.2M1.31%00.0%Unchanged
Ra Capital Management, L.P.1,515,151$17.5M0.24%00.0%Unchanged
CHI Advisors LLC1,515,148$17.5M5.10%00.0%Unchanged
Opaleye Management Inc.832,807$9.60M1.79%+105,007+14.4%Added
Janus Henderson Group PLC641,115$7.46M0.00%+40,155+6.7%Added
Vanguard Group Inc410,316$4.73M0.00%−254,054−38.2%Reduced
Vivo Capital, LLC399,830$4.61M0.21%−399,832−50.0%Reduced
Citadel Advisors LLC309,260$3.57M0.00%+1,117+0.4%Added
Atlas Venture Advisors, Inc.292,184$3.37M0.40%00.0%Unchanged
683 Capital Management, LLC256,620$2.96M0.15%00.0%Unchanged
Renaissance Technologies LLC246,274$2.84M0.00%+50,500+25.8%Added
BlackRock Inc.241,867$2.79M0.00%−10,033−4.0%Reduced
Driehaus Capital Management LLC210,500$2.43M0.03%00.0%Unchanged
Ghost Tree Capital, LLC200,000$2.31M0.76%+100,000+100.0%Added
Point72 Asset Management, L.P.196,896$2.27M0.01%+97,736+98.6%Added
Adage Capital Partners GP, L.L.C.176,680$2.04M0.00%+100,000+130.4%Added
Fred Alger Management, LLC175,870$2.03M0.00%+175,870New
Fi3 FINANCIAL ADVISORS, LLC121,818$1.41M0.93%00.0%Unchanged
Geode Capital Management, LLC114,060$1.31M0.00%+1,606+1.4%Added
BIT Capital GmbH94,016$1.08M0.06%+94,016New
Bank of America Corp81,810$944.0K0.00%+75,176+1,133.2%Added
Verition Fund Management LLC79,656$918.0K0.01%−165,019−67.4%Reduced
Susquehanna International Group, LLP69,817$805.0K0.00%+69,817New
DAFNA Capital Management LLC64,487$744.0K0.20%−12,500−16.2%Reduced
Ikarian Capital, LLC47,193$545.0K0.12%−5,775−10.9%Reduced
State Street Corp39,033$450.0K0.00%00.0%Unchanged
Morgan Stanley35,060$404.0K0.00%+472+1.4%Added
Asymmetry Capital Management, L.P.34,943$403.0K0.24%+34,943New
Two Sigma Advisers, LP32,898$379.0K0.00%+32,898New
Two Sigma Investments, LP30,607$353.0K0.00%+30,607New
Royce & Associates LP28,064$324.0K0.00%00.0%Unchanged
Marshall Wace, LLP26,587$306.0K0.00%+2,093+8.5%Added
Belvedere Trading LLC22,954$276.0K0.08%+22,954New
Northern Trust Corp23,498$271.0K0.00%−860−3.5%Reduced
HRT Financial LP21,174$244.0K0.00%+21,174New
Bank of New York Mellon Corp18,973$219.0K0.00%00.0%Unchanged
Dimensional Fund Advisors LP15,407$178.0K0.00%+15,407New
Citigroup Inc13,793$159.0K0.00%+75+0.5%Added
Goldman Sachs Group Inc13,053$151.0K0.00%−1,261−8.8%Reduced
Jane Street Group, LLC12,001$138.0K0.00%+12,001New
Northeast Financial Consultants Inc10,105$117.0K0.01%+10,105New
Tower Research Capital LLC (TRC)5,843$67.0K0.00%+4,498+334.4%Added
Solstein Capital, LLC4,477$52.0K0.03%00.0%Unchanged
Zurcher Kantonalbank (Zurich Cantonalbank)2,644$30.0K0.00%+9+0.3%Added
US Bancorp1,175$14.0K0.00%00.0%Unchanged
JPMorgan Chase & Co1,112$13.0K0.00%+361+48.1%Added
Group One Trading, L.P.1,000$12.0K0.00%+1,000New
Cubist Systematic Strategies, LLC793$9.00K0.00%−2,457−75.6%Reduced
Penserra Capital Management LLC405$4.00K0.00%+55+15.7%Added
Simplex Trading, LLC157$1.00K0.00%00.0%Unchanged
Disciplined Investments, LLC116$1.00K0.00%00.0%Unchanged
Daiwa Securities Group Inc.29$00.00%00.0%Unchanged
UBS Group AG8$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.29$00.00%+29New
Millennium Management LLC0$00.00%−257,868−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−10,163−100.0%Sold out
First Manhattan Co0$00.00%−4,000−100.0%Sold out
Acadian Asset Management LLC0$00.00%−457−100.0%Sold out